Table 5

Respiratory symptoms and airway inflammation associated with specific chemical agents and tasks used for patients’ skin/wound cleaning and disinfection in tertiary hospital health workers

n (%)Asthma symptom score†Asthma symptom score
(≥2 vs 0–1)
WRONSWRASFeNO, ppb‡
(n=654)
FeNO≥50 ppb
(n=654)
Prevalence (%) (n=697) 91 (13)109 (16)48 (7)41 (6)
Patients’ skin/wound cleaning and disinfection327 (47)1.06 (0.76 to 1.46)1.06 (0.64 to 1.77)1.20 (0.76 to 1.91)0.81 (0.41 to 1.61)1.10 (0.99 to 1.22)1.42 (0.68 to 2.96)
 Disinfect skin areas on patients prior to procedure
  Yes versus no253 (36)1.24 (0.91 to 1.69)1.37 (0.84 to 2.24) 1.79 (1.14 to 2.81)* 0.90 (0.45 to 1.77)1.03 (0.93 to 1.14)0.84 (0.41 to 1.71)
   0 min/week444 (74)111111
   1–99 min/week96 (16)1.11 (0.72 to 1.73)1.14 (0.57 to 2.28)1.73 (0.92 to 3.28)1.25 (0.50 to 3.14)1.01 (0.88 to 1.16)0.40 (0.12 to 1.40)
   ≥100 min/week58 (10)1.62 (0.98 to 2.68) 2.46 (1.19 to 5.09)* 2.23 (1.15 to 4.31)* 0.45 (0.11 to 1.97) 1.28 (1.08 to 1.52)* 2.20 (0.83 to 5.85)
 Clean and disinfect wounds
  Yes versus no162 (23)0.97 (0.67 to 1.39)1.07 (0.62 to 1.86)1.23 (0.72 to 2.10)1.34 (0.62 to 2.91)1.05 (0.94 to 1.19) 2.28 (1.06 to 4.91)*
   0 min/week535 (90)111111
   1–99 min/week39 (6)0.85 (0.44 to 1.65)0.85 (0.30 to 2.40)0.32 (0.08 to 1.38)0.41 (0.05 to 3.14)1.10 (0.90 to 1.34)0.60 (0.08 to 4.74)
   ≥100 min/week22 (4)1.52 (0.71 to 3.23) 3.14 (1.17 to 8.41)* 2.69 (1.03 to 7.01)* 3.15 (0.95 to 10.41) 1.32 (1.02 to 1.70)* 6.95 (2.31 to 20.91)**
 Apply wound dressing
  Yes versus no143 (21)0.97 (0.66 to 1.41)0.95 (0.54 to 1.69)1.68 (0.97 to 2.91)1.42 (0.64 to 3.15)0.93 (0.82 to 1.06)0.75 (0.31 to 1.81)
   0 min/week554 (90)111111
   1–99 min/week44 (7)0.93 (0.51 to 1.71)0.81 (0.30 to 2.20)0.91 (0.34 to 2.42)0.74 (0.17 to 3.26)1.12 (0.92 to 1.36)1.60 (0.51 to 5.01)
   ≥100 min/week18 (3)1.03 (0.44 to 2.42)2.06 (0.70 to 6.06)2.92 (0.96 to 8.92) 4.17 (1.19 to 14.64)* 0.88 (0.66 to 1.18)NC
 Use adhesives
  Yes versus no279 (40)1.19 (0.86 to 1.65)1.30 (0.78 to 2.18)1.42 (0.88 to 2.30)1.09 (0.54 to 2.21)1.02 (0.92 to 1.14)1.38 (0.65 to 2.93)
   0 min/week418 (69)111111
   1–99 min/week154 (26)1.35 (0.93 to 1.96)1.32 (0.72 to 2.42)1.43 (0.82 to 2.50)0.62 (0.23 to 1.64)1.07 (0.95 to 1.21)1.53 (0.67 to 3.49)
   ≥100 min/week30 (5)0.97 (0.49 to 1.93)1.64 (0.60 to 4.44) 2.41 (1.00 to 5.82)* 2.74 (0.93 to 8.10)1.04 (0.83 to 1.32)0.59 (0.07 to 4.77)
 Use adhesive removing solvents
  Yes versus no197 (28)1.26 (0.85 to 1.87)1.23 (0.68 to 2.22)1.30 (0.69 to 2.45)0.73 (0.29 to 1.82)1.02 (0.89 to 1.16)1.15 (0.47 to 2.80)
   0 mins/week500 (81)111111
   1–99 min/week105 (17)1.46 (0.92 to 2.30)1.10 (0.55 to 2.21)1.24 (0.59 to 2.62)0.24 (0.05 to 1.15)1.09 (0.93 to 1.27)1.64 (0.62 to 4.37)
   ≥100 min/week14 (2)1.42 (0.57 to 3.56)3.20 (0.93 to 10.99)2.52 (0.72 to 8.79)2.25 (0.43 to 11.85)0.98 (0.70 to 1.36)NC
  • Data are presented as OR (95% CI), unless otherwise indicated.

  • Adjusted for atopy, gender, smoking, age, study site and allergic sensitisation to natural rubber latex.

  • Bold values denote statistical significance at p<0.05 level.

  • *p<0.05, **p<0.01.

  • †Mean ratio (95% CI).

  • ‡Geometric mean ratio (95% CI).

  • FeNO, fractional exhaled nitric oxide; NC, not calculable; WRAS, work-related asthma symptoms; WRONS, work-related ocular-nasal symptoms.